Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opioid Antagonism in Hypogonadotropic Hypogonadism

NCT04975334 is registered in ClinicalTrials.gov with Stephanie B. Seminara, MD as lead sponsor.

NCT NCT04975334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opioid Antagonism in Hypogonadotropic Hypogonadism
Lead sponsor
Stephanie B. Seminara, MD
Phase
Phase 1
Overall status
Completed
Start date
June 18, 2025
Completion date
September 26, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadotropic hypogonadism, low testosterone